Cargando…

Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages

Evolved SARS-CoV-2 variants of concern (VOCs) spread through human populations in succession. Major virus variations are in the entry-facilitating viral spike (S) proteins; Omicron VOCs have 29–40 S mutations relative to ancestral D614G viruses. The impacts of this Omicron divergence on S protein st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qing, Enya, Gallagher, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470846/ https://www.ncbi.nlm.nih.gov/pubmed/37382441 http://dx.doi.org/10.1128/mbio.00171-23

Ejemplares similares

Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
por: Qing, Enya, et al.
Publicado: (2021)

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
por: Qing, Enya, et al.
Publicado: (2022)

Evaluating MERS-CoV Entry Pathways
por: Qing, Enya, et al.
Publicado: (2019)

Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles
por: Kumar, Binod, et al.
Publicado: (2021)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2021)

Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
por: Yuan, Kehu, et al.
Publicado: (2004)

Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
por: Guseman, Alex J., et al.
Publicado: (2022)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

Tetraspanins: Architects of Viral Entry and Exit Platforms
por: Hantak, Michael P., et al.
Publicado: (2019)

Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells
por: Raghavan, Somasundaram, et al.
Publicado: (2022)

Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
por: Chen, Yuliu, et al.
Publicado: (2022)

Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
por: Liang, Taizhen, et al.
Publicado: (2023)

Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein
por: Van Ert, Hanora A., et al.
Publicado: (2022)

Distinct conformational states of SARS-CoV-2 spike protein
por: Cai, Yongfei, et al.
Publicado: (2020)

Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein
por: Wang, Lin, et al.
Publicado: (2021)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
por: Kastenhuber, Edward R, et al.
Publicado: (2022)

SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
por: Yu, Shi, et al.
Publicado: (2023)

Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

SARS Coronavirus Redux
por: Qing, Enya, et al.
Publicado: (2020)

Role of Spike Protein Endodomains in Regulating Coronavirus Entry
por: Shulla, Ana, et al.
Publicado: (2009)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
por: Kemp, SA, et al.
Publicado: (2020)

LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
por: Song, Jaewon, et al.
Publicado: (2021)

Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection
por: Dong, Wenjuan, et al.
Publicado: (2023)

Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
por: Meng, Jie-Ru, et al.
Publicado: (2023)

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
por: Dieterle, M. Eugenia, et al.
Publicado: (2020)

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
por: He, Yuxian, et al.
Publicado: (2004)

A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition
por: Dieterle, M. Eugenia, et al.
Publicado: (2020)

SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
por: Kalkeri, Raj, et al.
Publicado: (2021)

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
por: Kim, Yunjeong, et al.
Publicado: (2021)

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
por: Kim, Yunjeong, et al.
Publicado: (2022)

Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
por: Qing, Enya, et al.
Publicado: (2020)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

SARS-CoV-2 spike and its adaptable furin cleavage site
por: Whittaker, Gary R
Publicado: (2021)

The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
por: López-Cortés, Georgina I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_27kjnqi6o3gife4qmj1na8qrb3